← All stocks

Mineralys Therapeutics, Inc.

MLYS Net selling

CIK 0001933414 #1952 in the set updated 17 Sep 2026

Bought (12 mo)

$8.76M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$84.34M

$7.78M on a plan · $24.12M straight out of an exercise

Sold at will

$52.44M

7 of 81 sales

Net

−$75.57M

−$43.68M against sales at will

By person

13 insiders · 84 transactions

24.6×

Jon Congleton holds 24.6 times base salary in stock. $15.68M of shares against $636.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jon Congleton last reported holding, valued at $25.98, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Slingsby Brian Taylor

Director

—

$43.35M (1)

−$43.35M

7,910,038

8.95%

$205.48M

−8.5%

Congleton Jon

Chief Executive Officer

—

$14.91M (17)

−$14.91M

603,621

0.6828%

$15.68M

−33.8%

Rodman David Malcom

Chief Medical Officer

—

$14.41M (39) scheduled

−$14.41M

51,384

0.0581%

$1.33M

−60.2%

RA CAPITAL MANAGEMENT, L.P. entity

Director

$8.76M (2)

—

+$8.76M

5,825,521

6.59%

$151.33M

+95.6%

Levy Adam Scott

CFO and Secretary

—

$6.16M (12) scheduled

−$6.16M

48,538

0.0549%

$1.26M

−69.8%

Warren Eric

Chief Commercial Officer

—

$3.09M (3) scheduled

−$3.09M

38,400

0.0434%

$997.51K

0.0%

Gold Alexander M

Director

—

$1.58M (5) scheduled

−$1.58M

6,200

0.0070%

$161.06K

—

Karydas Daphne

Director

—

$839.80K (4) scheduled

−$839.80K

6,200

0.0070%

$161.06K

—

Samsara BioCapital GP, LLC entity

10% owner

—

5,674,916

6.42%

$147.42M

+11.8%

AKKARAJU SRINIVAS

Director

—

594,435

0.6724%

$15.44M

—

Ferguson James J. III

Chief Medical Officer

—

102,400

0.1158%

$2.66M

—

SBLENDORIO GLENN

Director

—

6,200

0.0070%

$161.06K

—

DiRocco Derek

Director

—

6,200

0.0070%

$161.06K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

RA CAPITAL MANAGEMENT, L.P.

30 Mar 2026

Director

Buy indirect

58,300

$24.16

$1.41M

RA CAPITAL MANAGEMENT, L.P.

27 Mar 2026

Director

Buy indirect

310,700

$23.67

$7.35M

Show all 84 transactions →

Mineralys Therapeutics, Inc.

By person

Individual transactions

What was left out